Hypericum extract - Lichtwer Pharma

Drug Profile

Hypericum extract - Lichtwer Pharma

Alternative Names: LI 160; St John's Wort - Lichtwer Pharma

Latest Information Update: 06 May 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lichtwer Pharma
  • Class Antidepressants; Herbal medicines; Phytotherapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Major depressive disorder

Most Recent Events

  • 06 May 2002 A study has been added to the Affective Disorders therapeutic trials section
  • 07 Dec 2000 A study has been added to the Drug Interactions section
  • 23 Feb 2000 An interaction between LI 160 and indinavir has been added to the drug interactions section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top